Cargando…

Clinical Hematology International: Why a New Journal in Hematology?

Detalles Bibliográficos
Autores principales:	Mohty, Mohamad, Nagler, Arnon, Savani, Bipin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Atlantis Press 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432383/ https://www.ncbi.nlm.nih.gov/pubmed/34595404 http://dx.doi.org/10.2991/chi.d.190402.001

Ejemplares similares

Looking Ahead: Clinical Hematology International Turns One
por: Mohty, Mohamad, et al.
Publicado: (2020)

Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
por: Mohty, Mohamad, et al.
Publicado: (2020)

Another Year to Celebrate Advances in Clinical Hematology
por: Mohty, Mohamad, et al.
Publicado: (2023)

Journal of hematology & oncology: A journal open to all
por: Liu, Delong
Publicado: (2008)

Introducing Mediterranean Journal of Hematology and Infectious Diseases
por: Leone, Giuseppe, et al.
Publicado: (2009)

Immunotherapy for Multiple Myeloma
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Immunobiology and Pharmacologic Manipulation of Dendritic and Regulatory Cells
por: Mohty, Mohamad, et al.
Publicado: (2013)

Welcome to Volume 8 of the International Journal of Hematologic Oncology
por: Straiton, Jennifer
Publicado: (2019)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
por: Jang, Gwang Cheon
Publicado: (2019)

Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation
por: Kanate, Abraham S., et al.
Publicado: (2019)

A new platform for new promises in hematology
por: Cheng, Tao
Publicado: (2019)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

COVID-19 in Hematologic Malignancies: Big Challenges
por: Hu, Yongxian, et al.
Publicado: (2020)

The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia
por: Czyz, Anna, et al.
Publicado: (2019)

Launching the Israel Journal of Health Policy Research: Why a new journal? Why now? Why open access?
por: Rosen, Bruce, et al.
Publicado: (2012)

Best of hematology—2021
por: Prochazka, Katharina Theresa
Publicado: (2023)

Standardization in hematology and wine
por: McCann, Shaun
Publicado: (2023)

Diversity in hematology research
por: De Paula, Erich V
Publicado: (2023)

BMC Blood Disorders becomes BMC Hematology: evolving along with the hematology field
por: Chap, Christna
Publicado: (2013)

Weathering the storm: COVID-19 infection in patients with hematological malignancies
por: Wang, Lin-qin, et al.
Publicado: (2020)

Why a new journal in Public Health?
por: Gelatti, Umberto
Publicado: (2012)

Journal of Hematology & Oncology reviewer acknowledgement 2012
por: Liu, Delong
Publicado: (2013)

Journal of Hematology & Oncology reviewer acknowledgement 2013
por: Liu, Delong
Publicado: (2014)

Journal of Hematology & Oncology reviewer acknowledgement 2015
por: Liu, Delong
Publicado: (2016)

Journal of Hematology & Oncology reviewer acknowledgement 2014
por: Liu, Delong, et al.
Publicado: (2015)

Here to Stay: Biosimilars in Hematology
por: Gribben, John, et al.
Publicado: (2019)

Unanswered Questions in HIV Hematology
por: Leitch, Heather A., et al.
Publicado: (2012)

Blood Research: hematology and beyond
por: Stroncek, David F.
Publicado: (2013)

Drug Resistance in Hematological Malignancies
por: Auberger, Patrick, et al.
Publicado: (2020)

Nursing in patients with hematological malignancies
por: Geres, Hana, et al.
Publicado: (2020)

Immune Therapies for Hematologic Malignancies
por: Olnes, Matthew J.
Publicado: (2021)

Molecular Immunology in Hematological Disorders
por: Takami, Akiyoshi
Publicado: (2022)

Immune Microenvironment in Hematologic Malignancies
por: Arandi, Nargess, et al.
Publicado: (2023)

Journal of Ophthalmic Inflammation and Infection: why a new journal on ocular inflammation?
por: Rao, Narsing A.
Publicado: (2010)

Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)
por: Bahlis, Nizar J., et al.
Publicado: (2023)

China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year
por: Wang, Xiaochen
Publicado: (2022)

Publishing in Hematology Journals: A Scientometric and Economic Evaluation
por: Tazegul, Gokhan, et al.
Publicado: (2020)

Why is a new journal dedicated to echocardiography required?
por: Nihoyannopoulos, Petros
Publicado: (2014)

Paradoxes of hematology: When the old disappears and the new does not arrive
por: Maiolino, Angelo, et al.
Publicado: (2017)

New option for improving hematological recovery: suppression of luteinizing hormone
por: Elias, Harold K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iftdqb0n3rrs4a5bukq4307nj4